This small prospective split-face biopsy study found different tissue-response patterns after PDLLA and CaHA injections. Human tissue biopsies suggest different biological responses to two biostimulators, but the three-person pilot cannot establish clinical superiority.
Why this study is interesting
A prospective split-face pilot published on 14 October 2026 in Plastic and Reconstructive Surgery–Global Open compared poly-D,L-lactic acid (PDLLA) and calcium hydroxylapatite (CaHA) in human facial tissue. The researcher studied three women who received PDLLA on one side of the face and CaHA on the opposite side. Tissue was sampled three months later during planned facelift surgery.
Unlike many injectable studies that rely mainly on photographs or satisfaction scores, this project examined tissue directly with histology, immunohistochemical stains and high-frequency ultrasound. That approach can reveal biological signals that are not visible on surface images.
What did the biopsies show?
The paper reported more angiogenesis-related staining, fibroblast activation and early collagen remodeling in PDLLA-treated areas. CaHA-treated areas showed greater elastin-fiber density, including a reported 13% increase on one stain, and stronger CD34 expression. Ultrasound suggested early tissue thickening with CaHA. Both sides showed improvement on skin roughness and aesthetic assessment measures.
These observations are descriptive and hypothesis-generating. Markers such as CD31 and CD34 do not by themselves establish meaningful long-term regeneration or better patient outcomes.
The limitations are substantial
The study involved just three patients and six treated cheeks. With such a small sample, differences between individuals, injection patterns, baseline tissue and measurement variability can dominate results. The single three-month biopsy time point cannot establish how tissue responses evolve over a year or more.
The report did not provide evidence that one material is safer, longer lasting or more clinically effective than the other. Histological changes should not be equated with superior facial lifting, volumization or skin quality in routine practice.
Why it deserves coverage
Despite its limitations, the paper provides a useful reminder that biostimulators are not necessarily biologically identical. Future studies could standardize injection dose and plane, include baseline and serial biopsies, quantify adverse events and link tissue markers to validated clinical outcomes.
The author declared no relevant financial interest in the publication. For patients and clinicians, the central lesson is that different mechanisms deserve investigation, while decisions today should still rely on established indications, anatomy, safety and the quality of available human evidence.
What a stronger follow-up study might look like
A larger paired-face study could use standardized injection volumes and anatomical planes, repeated ultrasound measurements, blinded assessment and pre-specified tissue biomarkers. It would also need patient-centered endpoints such as perceived skin quality, durability and adverse events. Such a design could test whether the histological patterns observed in this small pilot consistently translate into meaningful clinical differences. Without that bridge, tissue staining should be treated as biological exploration, not a ranking of commercial products.
Original sources
Kim JS. Plastic and Reconstructive Surgery–Global Open, 14 October 2026: https://pubmed.ncbi.nlm.nih.gov/42872269/
DOI 10.1097/GOX.0000000000008090: https://doi.org/10.1097/GOX.0000000000008090
Source / evidence limitation: Peer-reviewed prospective pilot, n=3; no reliable comparative clinical superiority claim.
Medical disclaimer
This article is published by Aesthetics.news for general information and educational purposes only. It does not constitute medical advice, diagnosis or treatment, and should not replace a consultation with a qualified healthcare professional. Treatments and outcomes may vary from person to person. Readers should seek advice from an appropriately qualified professional before making decisions about their health or treatment. In a medical emergency, seek immediate medical assistance.